Park S, Pylaeva E, Bhuria V, Gambardella A, Schiavoni G, Mougiakakos D
Mol Cancer. 2025; 24(1):69.
PMID: 40050933
PMC: 11887392.
DOI: 10.1186/s12943-025-02249-2.
Wang Q, Yu M, Zhang S
Front Immunol. 2025; 15:1440830.
PMID: 39877377
PMC: 11772360.
DOI: 10.3389/fimmu.2024.1440830.
Xia Y, Huang C, Zhong M, Zhong H, Ruan R, Xiong J
Cell Commun Signal. 2025; 23(1):46.
PMID: 39856684
PMC: 11762533.
DOI: 10.1186/s12964-025-02033-1.
Wu X, Pan B, Chu C, Zhang Y, Ma J, Xing Y
Adv Sci (Weinh). 2024; 12(7):e2409537.
PMID: 39716908
PMC: 11831521.
DOI: 10.1002/advs.202409537.
Lee K, Mei Y, Liu H, Schwarz H
Mol Ther. 2024; 33(1):51-70.
PMID: 39668561
PMC: 11764688.
DOI: 10.1016/j.ymthe.2024.12.010.
Structure and regulatory mechanisms of food-derived peptides in inflammatory bowel disease: A review.
Qiu W, Wang Z, Liu Q, Du Q, Zeng X, Wu Z
Food Sci Nutr. 2024; 12(9):6055-6069.
PMID: 39554349
PMC: 11561845.
DOI: 10.1002/fsn3.4228.
Deciphering CD59: Unveiling Its Role in Immune Microenvironment and Prognostic Significance.
Patel B, Silwal A, Eltokhy M, Gaikwad S, Curcic M, Patel J
Cancers (Basel). 2024; 16(21).
PMID: 39518137
PMC: 11545456.
DOI: 10.3390/cancers16213699.
Circulating tumor cells: from new biological insights to clinical practice.
Gu X, Wei S, Lv X
Signal Transduct Target Ther. 2024; 9(1):226.
PMID: 39218931
PMC: 11366768.
DOI: 10.1038/s41392-024-01938-6.
Targeting tumor microenvironment for non-small cell lung cancer immunotherapy.
Wang L, Jia Q, Chu Q, Zhu B
Chin Med J Pulm Crit Care Med. 2024; 1(1):18-29.
PMID: 39170874
PMC: 11332857.
DOI: 10.1016/j.pccm.2022.11.001.
The potential immunological mechanisms of sepsis.
Zhang X, Zhang Y, Yuan S, Zhang J
Front Immunol. 2024; 15:1434688.
PMID: 39040114
PMC: 11260823.
DOI: 10.3389/fimmu.2024.1434688.
The Influence of Myeloid-Derived Suppressor Cell Expansion in Neuroinflammation and Neurodegenerative Diseases.
Tamberi L, Belloni A, Pugnaloni A, Rippo M, Olivieri F, Procopio A
Cells. 2024; 13(7.
PMID: 38607083
PMC: 11011419.
DOI: 10.3390/cells13070643.
The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice.
Shan F, Tang F, Liu Y, Han X, Wu W, Tang Y
Heliyon. 2024; 10(3):e25595.
PMID: 38356581
PMC: 10865327.
DOI: 10.1016/j.heliyon.2024.e25595.
Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells.
Wang X, Geng S, Meng J, Kang N, Liu X, Xu Y
J Clin Invest. 2023; 133(24).
PMID: 38099494
PMC: 10721146.
DOI: 10.1172/JCI163470.
Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation.
Lee J, Kim S, Sohn H, Kim C, Kim T, Lee H
Invest Ophthalmol Vis Sci. 2023; 64(13):39.
PMID: 37878302
PMC: 10615146.
DOI: 10.1167/iovs.64.13.39.
Short-chain fatty acids ameliorate allergic airway inflammation via sequential induction of PMN-MDSCs and Treg cells.
Huang M, Chiu C, Tsai C, Lee Y, Liu W, Chuang H
J Allergy Clin Immunol Glob. 2023; 2(4):100163.
PMID: 37781663
PMC: 10509984.
DOI: 10.1016/j.jacig.2023.100163.
Diverse functions of myeloid-derived suppressor cells in autoimmune diseases.
Xiong X, Zhang Y, Wen Y
Immunol Res. 2023; 72(1):34-49.
PMID: 37733169
PMC: 10811123.
DOI: 10.1007/s12026-023-09421-0.
Could the Crosstalk Between Myeloid-Derived-Suppressor Cells and Regulatory T Cells Have a Role in Beta-Thalassemia?.
Zahran A, El-Badawy O, Badawy E, Elsayh K, Gad E, Saad K
J Hematol. 2023; 12(4):161-169.
PMID: 37692868
PMC: 10482610.
DOI: 10.14740/jh1149.
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective.
Jin M, Jeong K
Exp Mol Med. 2023; 55(7):1333-1347.
PMID: 37394580
PMC: 10394043.
DOI: 10.1038/s12276-023-01014-z.
Adjuvant conditioning induces an immunosuppressive milieu that delays alloislet rejection through the expansion of myeloid-derived suppressor cells.
Ge J, Pan W, Feeney N, Ott L, Anderson E, Alessandrini A
Am J Transplant. 2023; 23(7):935-945.
PMID: 37080464
PMC: 10330215.
DOI: 10.1016/j.ajt.2023.04.015.
Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-naïve diffuse large B-cell lymphoma.
Wang H, Yang F, Yang C, Liu Y, Ko P, Li C
Exp Hematol Oncol. 2023; 12(1):35.
PMID: 37029450
PMC: 10080769.
DOI: 10.1186/s40164-023-00399-x.